Similar articles for PMID: 16162697

Year	Number of Results
1976	2
1978	1
1979	1
1981	1
1982	2
1983	1
1986	1
1987	1
1988	1
1989	3
1990	1
1991	1
1992	1
1993	3
1994	3
1995	5
1996	7
1997	4
1998	7
1999	9
2000	7
2001	12
2002	9
2003	21
2004	10
2005	14
2006	17
2007	11
2008	12
2009	15
2010	13
2011	7
2012	12
2013	7
2014	7
2015	14
2016	11
2017	18
2018	16
2019	18
2020	23
2021	29
2022	18
2023	8
2024	0

1

Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms.

Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK; Lansoprazole Asthma Study Group. Littner MR, et al. Chest. 2005 Sep;128(3):1128-35. doi: 10.1378/chest.128.3.1128. Chest. 2005. PMID: 16162697 Clinical Trial.

2

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial.

Writing Committee for the American Lung Association Asthma Clinical Research Centers; Holbrook JT, Wise RA, Gold BD, Blake K, Brown ED, Castro M, Dozor AJ, Lima JJ, Mastronarde JG, Sockrider MM, Teague WG. Writing Committee for the American Lung Association Asthma Clinical Research Centers, et al. JAMA. 2012 Jan 25;307(4):373-81. doi: 10.1001/jama.2011.2035. JAMA. 2012. PMID: 22274684 Free PMC article. Clinical Trial.

3

A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.

Shimizu Y, Dobashi K, Kobayashi S, Ohki I, Tokushima M, Kusano M, Kawamura O, Shimoyama Y, Utsugi M, Sunaga N, Ishizuka T, Mori M. Shimizu Y, et al. Tohoku J Exp Med. 2006 Jul;209(3):181-9. doi: 10.1620/tjem.209.181. Tohoku J Exp Med. 2006. PMID: 16778364 Free article. Clinical Trial.

4

Effect of omeprazole and domperidone on adult asthmatics with gastroesophageal reflux.

Sharma B, Sharma M, Daga MK, Sachdev GK, Bondi E. Sharma B, et al. World J Gastroenterol. 2007 Mar 21;13(11):1706-10. doi: 10.3748/wjg.v13.i11.1706. World J Gastroenterol. 2007. PMID: 17461474 Free PMC article. Clinical Trial.

5

Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.

Sandur V, Murugesh M, Banait V, Rathi PM, Bhatia SJ, Joshi JM, Kate A. Sandur V, et al. J Postgrad Med. 2014 Jul-Sep;60(3):282-6. doi: 10.4103/0022-3859.138754. J Postgrad Med. 2014. PMID: 25121368

6

Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy.

Wong CH, Chua CJ, Liam CK, Goh KL. Wong CH, et al. Aliment Pharmacol Ther. 2006 May 1;23(9):1321-7. doi: 10.1111/j.1365-2036.2006.02888.x. Aliment Pharmacol Ther. 2006. PMID: 16629937 Free article.

7

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA. Bjermer L, et al. Respir Med. 2000 Jun;94(6):612-21. doi: 10.1053/rmed.2000.0806. Respir Med. 2000. PMID: 10921768 Free article. Clinical Trial.

8

Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux.

Levin TR, Sperling RM, McQuaid KR. Levin TR, et al. Am J Gastroenterol. 1998 Jul;93(7):1060-3. doi: 10.1111/j.1572-0241.1998.329_q.x. Am J Gastroenterol. 1998. PMID: 9672330 Clinical Trial.

9

The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.

FitzGerald JM, Boulet LP, Follows RM. FitzGerald JM, et al. Clin Ther. 2005 Apr;27(4):393-406. doi: 10.1016/j.clinthera.2005.03.006. Clin Ther. 2005. PMID: 15922813 Clinical Trial.

10

Management of symptoms in step-down therapy of gastroesophageal reflux disease.

Mine S, Iida T, Tabata T, Kishikawa H, Tanaka Y. Mine S, et al. J Gastroenterol Hepatol. 2005 Sep;20(9):1365-70. doi: 10.1111/j.1440-1746.2005.03980.x. J Gastroenterol Hepatol. 2005. PMID: 16105122 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

352 results

Results by year